ARENA PHARMACEUTICALS INC - FORM 10-Q - EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER - May 10, 2011

Attached files

file filename
10-Q - FORM 10-Q - ARENA PHARMACEUTICALS INCd10q.htm
EX-3.7 - CERTIFICATE OF DESIGNATION OF PREFERENCES - ARENA PHARMACEUTICALS INCdex37.htm
EX-10.2 - AMENDMENT NO.1 TO THE ASSET PURCHASE AGREEMENT - ARENA PHARMACEUTICALS INCdex102.htm
EX-10.3 - AMENDMENT NO.3 TO THE TOLL MANUFACTURING AGREEMENT - ARENA PHARMACEUTICALS INCdex103.htm
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE AND FINANCIAL OFFICER - ARENA PHARMACEUTICALS INCdex311.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Arena Pharmaceuticals, Inc. (the “Company”) for the period ended March 31, 2011, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Jack Lief, as President and Chief Executive Officer (principal executive and financial officer) of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

 

  1. the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Jack Lief

Jack Lief
President and Chief Executive Officer
(principal executive and financial officer)
Date: May 10, 2011

ARENA PHARMACEUTICALS INC Reports